APO Research
Talk to an analyst

APO RESEARCH · REPORT

Succinate Dehydrogenase Inhibitor (SDHI)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Succinate Dehydrogenase Inhibitor (SDHI) Market Outlook and Growth Opportunities 2026

3 May 2026192 pages

Choose your research edition.

Industry ResearchSuccinate Dehydrogenase Inhibitor (SDHI) Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Succinate Dehydrogenase Inhibitor (SDHI) Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Succinate Dehydrogenase Inhibitor (SDHI) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Succinate Dehydrogenase Inhibitor (SDHI) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Succinate Dehydrogenase Inhibitor (SDHI) Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Succinate Dehydrogenase Inhibitor (SDHI) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Succinate Dehydrogenase Inhibitor (SDHI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Succinate Dehydrogenase Inhibitor (SDHI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Succinate Dehydrogenase Inhibitor (SDHI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Succinate Dehydrogenase Inhibitor (SDHI) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Succinate Dehydrogenase Inhibitor (SDHI) market include BASF SE, UPL Limited, Syngenta AG, Sumitomo Chemical Co., Ltd., Nufarm Limited, ISK Biosciences Corporation, Great Chem, FMC Corporation and Corteva Agriscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Succinate Dehydrogenase Inhibitor (SDHI) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Succinate Dehydrogenase Inhibitor (SDHI) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Succinate Dehydrogenase Inhibitor (SDHI) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Succinate Dehydrogenase Inhibitor (SDHI) market size, projected growth trends, production technologies, key applications, and end-use industries.

Succinate Dehydrogenase Inhibitor (SDHI) Segment by Company

BASF SE

UPL Limited

Syngenta AG

Sumitomo Chemical Co., Ltd.

Nufarm Limited

ISK Biosciences Corporation

Great Chem

FMC Corporation

Corteva Agriscience

Bayer

ADAMA Agricultural Solutions Ltd.

Succinate Dehydrogenase Inhibitor (SDHI) Segment by Type

Boscalid

Sedaxane

Penflufen

Fluxapyroxad

Bixafen

Others

Succinate Dehydrogenase Inhibitor (SDHI) Segment by Application

Vegetable

Fruit Tree

Cereals

Others

Succinate Dehydrogenase Inhibitor (SDHI) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Succinate Dehydrogenase Inhibitor (SDHI) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Succinate Dehydrogenase Inhibitor (SDHI) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Succinate Dehydrogenase Inhibitor (SDHI) significant trends, drivers, influence factors in global and regions.

6. To analyze Succinate Dehydrogenase Inhibitor (SDHI) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Succinate Dehydrogenase Inhibitor (SDHI) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Succinate Dehydrogenase Inhibitor (SDHI) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Succinate Dehydrogenase Inhibitor (SDHI).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Succinate Dehydrogenase Inhibitor (SDHI) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Succinate Dehydrogenase Inhibitor (SDHI) industry.

Chapter 3: Detailed analysis of Succinate Dehydrogenase Inhibitor (SDHI) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Succinate Dehydrogenase Inhibitor (SDHI) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Succinate Dehydrogenase Inhibitor (SDHI) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Succinate Dehydrogenase Inhibitor (SDHI) Industry Trends Table 2. Succinate Dehydrogenase Inhibitor (SDHI) Industry Drivers Table 3. Succinate Dehydrogenase Inhibitor (SDHI) Industry Opportunities and Challenges Table 4. Succinate Dehydrogenase Inhibitor (SDHI) Industry Restraints Table 5. Global Succinate Dehydrogenase Inhibitor (SDHI) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Succinate Dehydrogenase Inhibitor (SDHI) Revenue Share by Company (2021-2026) Table 7. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Company (t) & (2021-2026) Table 8. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume Share by Company (2021-2026) Table 9. Global Succinate Dehydrogenase Inhibitor (SDHI) Average Price (USD/t) of Company (2021-2026) Table 10. Global Succinate Dehydrogenase Inhibitor (SDHI) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Succinate Dehydrogenase Inhibitor (SDHI) Key Company Manufacturing Base & Headquarters Table 12. Global Succinate Dehydrogenase Inhibitor (SDHI) Company, Product Type & Application Table 13. Global Succinate Dehydrogenase Inhibitor (SDHI) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Succinate Dehydrogenase Inhibitor (SDHI) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Boscalid Table 18. Significant Companies of Sedaxane Table 19. Significant Companies of Penflufen Table 20. Significant Companies of Fluxapyroxad Table 21. Significant Companies of Bixafen Table 22. Significant Companies of Others Table 23. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 24. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Type (2021-2026) & (t) Table 25. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Type (2027-2032) & (t) Table 26. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume Share by Type (2021-2026) Table 27. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume Share by Type (2027-2032) Table 28. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type (2021-2026) Table 32. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Vegetable Table 34. Significant Companies of Fruit Tree Table 35. Significant Companies of Cereals Table 36. Significant Companies of Others Table 37. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 38. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Application (2021-2026) & (t) Table 39. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Application (2027-2032) & (t) Table 40. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume Share by Application (2021-2026) Table 41. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume Share by Application (2027-2032) Table 42. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application (2021-2026) Table 46. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application (2027-2032) Table 47. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Region: 2021 VS 2025 VS 2032 (t) Table 48. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Region (2021-2026) & (t) Table 49. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Market Share by Region (2021-2026) Table 50. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Region (2027-2032) & (t) Table 51. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Market Share by Region (2027-2032) Table 52. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Region (2021-2026) Table 55. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Region (2027-2032) Table 57. Global Succinate Dehydrogenase Inhibitor (SDHI) Market Average Price (USD/t) by Region (2021-2026) Table 58. Global Succinate Dehydrogenase Inhibitor (SDHI) Market Average Price (USD/t) by Region (2027-2032) Table 59. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Country: 2021 VS 2025 VS 2032 (t) Table 60. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Country (2021-2026) & (t) Table 62. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Market Share by Country (2021-2026) Table 63. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Country (2027-2032) & (t) Table 64. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Market Share by Country (2027-2032) Table 65. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Market Share by Country (2021-2026) Table 67. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Market Share by Country (2027-2032) Table 69. BASF SE Company Information Table 70. BASF SE Business Overview Table 71. BASF SE Succinate Dehydrogenase Inhibitor (SDHI) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 72. BASF SE Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio Table 73. BASF SE Recent Development Table 74. UPL Limited Company Information Table 75. UPL Limited Business Overview Table 76. UPL Limited Succinate Dehydrogenase Inhibitor (SDHI) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 77. UPL Limited Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio Table 78. UPL Limited Recent Development Table 79. Syngenta AG Company Information Table 80. Syngenta AG Business Overview Table 81. Syngenta AG Succinate Dehydrogenase Inhibitor (SDHI) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 82. Syngenta AG Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio Table 83. Syngenta AG Recent Development Table 84. Sumitomo Chemical Co., Ltd. Company Information Table 85. Sumitomo Chemical Co., Ltd. Business Overview Table 86. Sumitomo Chemical Co., Ltd. Succinate Dehydrogenase Inhibitor (SDHI) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 87. Sumitomo Chemical Co., Ltd. Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio Table 88. Sumitomo Chemical Co., Ltd. Recent Development Table 89. Nufarm Limited Company Information Table 90. Nufarm Limited Business Overview Table 91. Nufarm Limited Succinate Dehydrogenase Inhibitor (SDHI) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 92. Nufarm Limited Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio Table 93. Nufarm Limited Recent Development Table 94. ISK Biosciences Corporation Company Information Table 95. ISK Biosciences Corporation Business Overview Table 96. ISK Biosciences Corporation Succinate Dehydrogenase Inhibitor (SDHI) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 97. ISK Biosciences Corporation Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio Table 98. ISK Biosciences Corporation Recent Development Table 99. Great Chem Company Information Table 100. Great Chem Business Overview Table 101. Great Chem Succinate Dehydrogenase Inhibitor (SDHI) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 102. Great Chem Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio Table 103. Great Chem Recent Development Table 104. FMC Corporation Company Information Table 105. FMC Corporation Business Overview Table 106. FMC Corporation Succinate Dehydrogenase Inhibitor (SDHI) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 107. FMC Corporation Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio Table 108. FMC Corporation Recent Development Table 109. Corteva Agriscience Company Information Table 110. Corteva Agriscience Business Overview Table 111. Corteva Agriscience Succinate Dehydrogenase Inhibitor (SDHI) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 112. Corteva Agriscience Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio Table 113. Corteva Agriscience Recent Development Table 114. Bayer Company Information Table 115. Bayer Business Overview Table 116. Bayer Succinate Dehydrogenase Inhibitor (SDHI) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 117. Bayer Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio Table 118. Bayer Recent Development Table 119. ADAMA Agricultural Solutions Ltd. Company Information Table 120. ADAMA Agricultural Solutions Ltd. Business Overview Table 121. ADAMA Agricultural Solutions Ltd. Succinate Dehydrogenase Inhibitor (SDHI) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 122. ADAMA Agricultural Solutions Ltd. Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio Table 123. ADAMA Agricultural Solutions Ltd. Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Succinate Dehydrogenase Inhibitor (SDHI) Distributors List Table 127. Succinate Dehydrogenase Inhibitor (SDHI) Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Succinate Dehydrogenase Inhibitor (SDHI) Product Image Figure 2. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales (2021-2032) & (t) Figure 5. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Succinate Dehydrogenase Inhibitor (SDHI) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Boscalid Image Figure 10. Sedaxane Image Figure 11. Penflufen Image Figure 12. Fluxapyroxad Image Figure 13. Bixafen Image Figure 14. Others Image Figure 15. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 16. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume Share by Type (2021-2032) Figure 18. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type (2021-2032) Figure 21. Vegetable Image Figure 22. Fruit Tree Image Figure 23. Cereals Image Figure 24. Others Image Figure 25. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 26. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume Share by Application (2021-2032) Figure 28. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application (2021-2032) Figure 31. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 32. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Succinate Dehydrogenase Inhibitor (SDHI) Sales Value (2021-2032) & (US$ Million) Figure 36. North America Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Succinate Dehydrogenase Inhibitor (SDHI) Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Succinate Dehydrogenase Inhibitor (SDHI) Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Succinate Dehydrogenase Inhibitor (SDHI) Sales Value (2021-2032) & (US$ Million) Figure 42. South America Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Succinate Dehydrogenase Inhibitor (SDHI) Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Succinate Dehydrogenase Inhibitor (SDHI) Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Succinate Dehydrogenase Inhibitor (SDHI) Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Boscalid
  • Sedaxane
  • Penflufen
  • Fluxapyroxad
  • Bixafen
  • Others
Applications
  • Vegetable
  • Fruit Tree
  • Cereals
  • Others
Companies covered
  • BASF SE
  • UPL Limited
  • Syngenta AG
  • Sumitomo Chemical Co., Ltd.
  • Nufarm Limited
  • ISK Biosciences Corporation
  • Great Chem
  • FMC Corporation
  • Corteva Agriscience
  • Bayer
  • ADAMA Agricultural Solutions Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value (2021-2032)
  4. 1.2.2 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume (2021-2032)
  5. 1.2.3 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Succinate Dehydrogenase Inhibitor (SDHI) Market Dynamics
  1. 2.1 Succinate Dehydrogenase Inhibitor (SDHI) Industry Trends
  2. 2.2 Succinate Dehydrogenase Inhibitor (SDHI) Industry Drivers
  3. 2.3 Succinate Dehydrogenase Inhibitor (SDHI) Industry Opportunities and Challenges
  4. 2.4 Succinate Dehydrogenase Inhibitor (SDHI) Industry Restraints
3 Succinate Dehydrogenase Inhibitor (SDHI) Market by Company
  1. 3.1 Global Succinate Dehydrogenase Inhibitor (SDHI) Company Revenue Ranking in 2025
  2. 3.2 Global Succinate Dehydrogenase Inhibitor (SDHI) Revenue by Company (2021-2026)
  3. 3.3 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Company (2021-2026)
  4. 3.4 Global Succinate Dehydrogenase Inhibitor (SDHI) Average Price by Company (2021-2026)
  5. 3.5 Global Succinate Dehydrogenase Inhibitor (SDHI) Company Ranking (2024-2026)
  6. 3.6 Global Succinate Dehydrogenase Inhibitor (SDHI) Company Manufacturing Base and Headquarters
  7. 3.7 Global Succinate Dehydrogenase Inhibitor (SDHI) Company Product Type and Application
  8. 3.8 Global Succinate Dehydrogenase Inhibitor (SDHI) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Succinate Dehydrogenase Inhibitor (SDHI) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Succinate Dehydrogenase Inhibitor (SDHI) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Succinate Dehydrogenase Inhibitor (SDHI) Market by Type
  1. 4.1 Succinate Dehydrogenase Inhibitor (SDHI) Type Introduction
  2. 4.1.1 Boscalid
  3. 4.1.2 Sedaxane
  4. 4.1.3 Penflufen
  5. 4.1.4 Fluxapyroxad
  6. 4.1.5 Bixafen
  7. 4.1.6 Others
  8. 4.2 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Type
  9. 4.2.1 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Type
  13. 4.3.1 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Type (2021-2032)
  15. 4.3.3 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type (2021-2032)
5 Succinate Dehydrogenase Inhibitor (SDHI) Market by Application
  1. 5.1 Succinate Dehydrogenase Inhibitor (SDHI) Application Introduction
  2. 5.1.1 Vegetable
  3. 5.1.2 Fruit Tree
  4. 5.1.3 Cereals
  5. 5.1.4 Others
  6. 5.2 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Application
  7. 5.2.1 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Application
  11. 5.3.1 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application (2021-2032)
6 Succinate Dehydrogenase Inhibitor (SDHI) Regional Sales and Value Analysis
  1. 6.1 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Region (2021-2032)
  3. 6.2.1 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Region: 2021-2026
  4. 6.2.2 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Region (2027-2032)
  5. 6.3 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Region (2027-2032)
  9. 6.5 Global Succinate Dehydrogenase Inhibitor (SDHI) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Succinate Dehydrogenase Inhibitor (SDHI) Sales Value (2021-2032)
  12. 6.6.2 North America Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Succinate Dehydrogenase Inhibitor (SDHI) Sales Value (2021-2032)
  15. 6.7.2 Europe Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Succinate Dehydrogenase Inhibitor (SDHI) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Succinate Dehydrogenase Inhibitor (SDHI) Sales Value (2021-2032)
  21. 6.9.2 South America Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Succinate Dehydrogenase Inhibitor (SDHI) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Country, 2025 VS 2032
7 Succinate Dehydrogenase Inhibitor (SDHI) Country-level Sales and Value Analysis
  1. 7.1 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Country (2021-2032)
  4. 7.3.1 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Country (2021-2026)
  5. 7.3.2 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales by Country (2027-2032)
  6. 7.4 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Succinate Dehydrogenase Inhibitor (SDHI) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Succinate Dehydrogenase Inhibitor (SDHI) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BASF SE
  2. 8.1.1 BASF SE Company Information
  3. 8.1.2 BASF SE Business Overview
  4. 8.1.3 BASF SE Succinate Dehydrogenase Inhibitor (SDHI) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BASF SE Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio
  6. 8.1.5 BASF SE Recent Developments
  7. 8.2 UPL Limited
  8. 8.2.1 UPL Limited Company Information
  9. 8.2.2 UPL Limited Business Overview
  10. 8.2.3 UPL Limited Succinate Dehydrogenase Inhibitor (SDHI) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 UPL Limited Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio
  12. 8.2.5 UPL Limited Recent Developments
  13. 8.3 Syngenta AG
  14. 8.3.1 Syngenta AG Company Information
  15. 8.3.2 Syngenta AG Business Overview
  16. 8.3.3 Syngenta AG Succinate Dehydrogenase Inhibitor (SDHI) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Syngenta AG Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio
  18. 8.3.5 Syngenta AG Recent Developments
  19. 8.4 Sumitomo Chemical Co., Ltd.
  20. 8.4.1 Sumitomo Chemical Co., Ltd. Company Information
  21. 8.4.2 Sumitomo Chemical Co., Ltd. Business Overview
  22. 8.4.3 Sumitomo Chemical Co., Ltd. Succinate Dehydrogenase Inhibitor (SDHI) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sumitomo Chemical Co., Ltd. Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio
  24. 8.4.5 Sumitomo Chemical Co., Ltd. Recent Developments
  25. 8.5 Nufarm Limited
  26. 8.5.1 Nufarm Limited Company Information
  27. 8.5.2 Nufarm Limited Business Overview
  28. 8.5.3 Nufarm Limited Succinate Dehydrogenase Inhibitor (SDHI) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nufarm Limited Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio
  30. 8.5.5 Nufarm Limited Recent Developments
  31. 8.6 ISK Biosciences Corporation
  32. 8.6.1 ISK Biosciences Corporation Company Information
  33. 8.6.2 ISK Biosciences Corporation Business Overview
  34. 8.6.3 ISK Biosciences Corporation Succinate Dehydrogenase Inhibitor (SDHI) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 ISK Biosciences Corporation Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio
  36. 8.6.5 ISK Biosciences Corporation Recent Developments
  37. 8.7 Great Chem
  38. 8.7.1 Great Chem Company Information
  39. 8.7.2 Great Chem Business Overview
  40. 8.7.3 Great Chem Succinate Dehydrogenase Inhibitor (SDHI) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Great Chem Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio
  42. 8.7.5 Great Chem Recent Developments
  43. 8.8 FMC Corporation
  44. 8.8.1 FMC Corporation Company Information
  45. 8.8.2 FMC Corporation Business Overview
  46. 8.8.3 FMC Corporation Succinate Dehydrogenase Inhibitor (SDHI) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 FMC Corporation Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio
  48. 8.8.5 FMC Corporation Recent Developments
  49. 8.9 Corteva Agriscience
  50. 8.9.1 Corteva Agriscience Company Information
  51. 8.9.2 Corteva Agriscience Business Overview
  52. 8.9.3 Corteva Agriscience Succinate Dehydrogenase Inhibitor (SDHI) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Corteva Agriscience Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio
  54. 8.9.5 Corteva Agriscience Recent Developments
  55. 8.10 Bayer
  56. 8.10.1 Bayer Company Information
  57. 8.10.2 Bayer Business Overview
  58. 8.10.3 Bayer Succinate Dehydrogenase Inhibitor (SDHI) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bayer Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio
  60. 8.10.5 Bayer Recent Developments
  61. 8.11 ADAMA Agricultural Solutions Ltd.
  62. 8.11.1 ADAMA Agricultural Solutions Ltd. Company Information
  63. 8.11.2 ADAMA Agricultural Solutions Ltd. Business Overview
  64. 8.11.3 ADAMA Agricultural Solutions Ltd. Succinate Dehydrogenase Inhibitor (SDHI) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ADAMA Agricultural Solutions Ltd. Succinate Dehydrogenase Inhibitor (SDHI) Product Portfolio
  66. 8.11.5 ADAMA Agricultural Solutions Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Succinate Dehydrogenase Inhibitor (SDHI) Value Chain Analysis
  2. 9.1.1 Succinate Dehydrogenase Inhibitor (SDHI) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Succinate Dehydrogenase Inhibitor (SDHI) Sales Mode & Process
  6. 9.2 Succinate Dehydrogenase Inhibitor (SDHI) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Succinate Dehydrogenase Inhibitor (SDHI) Distributors
  9. 9.2.3 Succinate Dehydrogenase Inhibitor (SDHI) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst